Loading organizations...
§ Venture Capital
Venture capital firm funding early-stage biotech and healthcare companies, supporting new technologies and business development.
Hiaqua Investments is a venture capital firm that invests in early-stage and growth companies, primarily within the biotech and healthcare sectors. The firm provides capital to support innovative technologies and business development, with a strategic focus on areas such as genomics, synthetic antibodies, and PCR-based diagnostics. Hiaqua Investments recently participated as a co-investor in a Series C round for portfolio company Arima Genomics, which secured $22 million in funding to advance its genomic analysis platforms. The firm has also co-invested alongside notable entities including Vectr Ventures, Agilent Technologies, Illumina Ventures, Tech Coast Angels, and Berkeley Catalyst Fund in various funding rounds for promising life science ventures. Their investment strategy targets advancements in novel cell assay platforms and other cutting-edge technologies poised to transform medical diagnostics and therapeutics.
Hiaqua Investments has 1 tracked investment across 1 company. The latest tracked deal is $7.0M Series B in Arima Genomics in March 2022.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 15, 2022 | Arima Genomics | $7.0M Series B | — | Darlene Solomon, Berkeley Catalyst Fund, Co WIN Ventures, HAI YAN, Ladder Ventures, Tech Coast Angels, Vectr Ventures |